학술논문
Daratumumab in Combination with Carfilzomib and Dexamethasone in Patients (pts) with Relapsed Multiple Myeloma (MMY1001): An Open-Label, Phase 1b Study
Document Type
Abstract
Author
Source
In Blood 8 December 2017 130 Supplement 1:1869-1869
Subject
Language
ISSN
0006-4971